Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Aging (Upcoming)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Prostaglandin E2 reduces radiation-induced epithelial apoptosis through a mechanism involving AKT activation and bax translocation
Teresa G. Tessner, … , Shrikant Anant, William F. Stenson
Teresa G. Tessner, … , Shrikant Anant, William F. Stenson
Published December 1, 2004
Citation Information: J Clin Invest. 2004;114(11):1676-1685. https://doi.org/10.1172/JCI22218.
View: Text | PDF
Article

Prostaglandin E2 reduces radiation-induced epithelial apoptosis through a mechanism involving AKT activation and bax translocation

  • Text
  • PDF
Abstract

Prostaglandin E2 (PGE2) synthesis modulates the response to radiation injury in the mouse intestinal epithelium through effects on crypt survival and apoptosis; however, the downstream signaling events have not been elucidated. WT mice receiving 16,16-dimethyl PGE2 (dmPGE2) had fewer apoptotic cells per crypt than untreated mice. Apoptosis in Bax–/– mice receiving 12 Gy was approximately 50% less than in WT mice, and the ability of dmPGE2 to attenuate apoptosis was lost in Bax–/– mice. Positional analysis revealed that apoptosis in the Bax–/– mice was diminished only in the bax-expressing cells of the lower crypts and that in WT mice, dmPGE2 decreased apoptosis only in the bax-expressing cells. The HCT-116 intestinal cell line and Bax–/– HCT-116 recapitulated the apoptotic response of the mouse small intestine with regard to irradiation and dmPGE2. Irradiation of HCT-116 cells resulted in phosphorylation of AKT that was enhanced by dmPGE2 through transactivation of the EGFR. Inhibition of AKT phosphorylation prevented the reduction of apoptosis by dmPGE2 following radiation. Transfection of HCT-116 cells with a constitutively active AKT reduced apoptosis in irradiated cells to the same extent as in nontransfected cells treated with dmPGE2. Treatment with dmPGE2 did not alter bax or bcl-x expression but suppressed bax translocation to the mitochondrial membrane. Our in vivo studies indicate that there are bax-dependent and bax-independent radiation-induced apoptosis in the intestine but that only the bax-dependent apoptosis is reduced by dmPGE2. The in vitro studies indicate that dmPGE2, most likely by signaling through the E prostaglandin receptor EP2, reduces radiation-induced apoptosis through transactivation of the EGFR and enhanced activation of AKT and that this results in reduced bax translocation to the mitochondria.

Authors

Teresa G. Tessner, Filipe Muhale, Terrence E. Riehl, Shrikant Anant, William F. Stenson

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Apoptosis and crypt survival in dmPGE2-treated irradiated WT and Bax–/– ...
Apoptosis and crypt survival in dmPGE2-treated irradiated WT and Bax–/– mice. (A) Apoptotic index. WT or Bax–/– mice received vehicle or dmPGE2 (0.5 mg/kg) 1 hour prior to irradiation (12 Gy). Mice were killed 6 hours after radiation, and the cell-positional distribution of apoptosis in the crypts was scored. Data are the mean ± SEM. *P < 0.05, WT compared with Bax–/– or with Bax–/– plus dmPGE2; P < 0.05, WT compared with WT plus dmPGE2, Bax–/–, or Bax–/– plus dmPGE2. WT, n = 8; WT plus dmPGE2, n = 4; Bax–/–, n = 6; Bax–/– plus dmPGE2, n = 4. (B) Apoptotic cells in small-intestinal crypts 6 hours after radiation. WT or Bax–/– mice received vehicle (white bars) or dmPGE2 (black bars) 1 hour prior to irradiation. Mice were killed 6 hours after radiation, and the number of apoptotic cells per crypt was scored. Data are the mean ± SEM. *P < 0.05; **P < 0.0001 compared with WT plus vehicle. WT plus vehicle, n = 16; WT plus dmPGE2, n = 4; Bax–/– plus vehicle, n = 7; Bax–/– plus dmPGE2, n = 4. (C) Crypt survival. WT or Bax–/– mice received vehicle (white bars) or dmPGE2 (black bars) 1 hour prior to irradiation. Mice were killed 84 hours after radiation, and the number of surviving crypts per cross section was scored. Data are the mean ± SEM. *P < 0.05; **P < 0.0001. WT plus vehicle, n = 7; WT plus dmPGE2, n = 4; Bax–/– plus vehicle, n = 12; Bax–/– plus dmPGE2, n = 8.

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts